Skip to main content
. 2018 Mar 20;6(3):e1715. doi: 10.1097/GOX.0000000000001715

Fig. 3.

Fig. 3.

Landmark distributions. A, Frontal view of facial landmark distributions over all subjects (patients with CL/P and controls) in sample 1. B, Frontal view of facial landmark distributions over all subjects (patients with FP and controls) in sample 2.